Clinical Success,
Accelerated

Seeing What Conventional Methods Miss

Our Virtual Cell-to-Patient profiling technology bridges the gap between raw data & clinical reality. We transform hidden cellular insights into definitive therapeutic breakthroughs—from novel targets to validated biomarkers.

How?

The Stratification Dilemma

ExpensiveLongHard

What if we could get you single-cell clarity from your bulk or image samples?

De-risk Patient Stratification through Large-scale Virtual Patient Profiling

Turn Uncertainty Into Confidence

Regulator-ready patient stratification without the single-cell burden

Check outLEIBER-X

Unrivaled Precision
Accelerated Marker Driven Discovery
Clinical Trial De-risking

How We De-Risk Your Journey

Virtual Cell technology transforms your archived bulk RNA samples or pathological image data including H&E, IHC into regulator-ready stratification insights

Learn more

Accelerate Enrollment

Identify true responder populations with 7x higher precision, reducing screen failures and meeting recruitment timelines.

Predict Responders Earlier

Model patient responses before dosing, enabling earlier go/no-go decisions and reducing late-stage failures.

Unlock Hidden Value

Extract cellular-level biomarkers from archived bulk RNA samples, revealing stratification opportunities you already paid for.

Stratify At Trial Scale

Profile 1,000 patients for the cost of 150 single-cell samples, making comprehensive stratification economically feasible.

Trusted By Leading Programs

Validated across 5+ cancer types with pharma and academic partners

Request Demo

Cancer Types

Validated across diverse oncology indications

1.3B+

Single Cells

Comprehensive atlas powering Virtual Cell predictions

95%

Cost Savings

versus traditional single-cell profiling at scale

Clinical Success,Accelerated